We recommend adding Resmed to your watch list.
RMDis a global company involved in the development and manufacturing of medical products for the treatment of respiratory disorders. Global mask sales increased 10%+ on the same time last year.
You're not a member! Trial today
Low returns from new acquisitions, disappointed investors and the soft 2Q19 earnings update resulted in the stock falling by over 10%
It’s difficult to say with certainly where buyers will step back in, but we are confident of the long-term story with Resmed.
The chart below illustrates the lower band where we see deep value for investors willing to take a 1 – 3 year outlook.
